T865-3350 Screening compound: PIPERIDINO[(3S,4R)-4-(3-PYRIDYL)-1-(4-PYRIDYLCARBONYL)TETRAHYDRO-1H-PYRROL-3-YL]METHANONE

T865-3350 Screening compound: PIPERIDINO[(3S,4R)-4-(3-PYRIDYL)-1-(4-PYRIDYLCARBONYL)TETRAHYDRO-1H-PYRROL-3-YL]METHANONE
T865-3350 Screening compound: PIPERIDINO[(3S,4R)-4-(3-PYRIDYL)-1-(4-PYRIDYLCARBONYL)TETRAHYDRO-1H-PYRROL-3-YL]METHANONE alternative view

Chemical Structure Depiction of ChemDiv screening compound T865-3350
PIPERIDINO[(3S,4R)-4-(3-PYRIDYL)-1-(4-PYRIDYLCARBONYL)TETRAHYDRO-1H-PYRROL-3-YL]METHANONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T865-3350

Molecular Formula

C21H24N4O2 (C21 H24 N4 O2)

Compound Name

PIPERIDINO[(3S,4R)-4-(3-PYRIDYL)-1-(4-PYRIDYLCARBONYL)TETRAHYDRO-1H-PYRROL-3-YL]METHANONE

IUPAC name

n/a

SMILES

O=C([C@@H](CN(C1)C(c2ccncc2)=O)[C@H]1c1cnccc1)N1CCCCC1

InChI

InChI=1S/C21H24N4O2/c26-20(16-6-9-22-10-7-16)25-14-18(17-5-4-8-23-13-17)19(15-25)21(27)24-11-2-1-3-12-24/h4-10,13,18-19H,1-3,11-12,14-15H2/t18-,19+/m0/s1

InChI Key

BVUZAGVMUKUAAX-RBUKOAKNSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

364.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

0.883

Distribution Coefficient, logD

0.881

Water Solubility, LogSw

-1.24

Polar Surface Area

52.442

Acid Dissociation Constant (pKa)

21.25

Base Dissociation Constant (pKb)

5.14

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.90

T865-3350 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T865-3350 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T865-3350?
Check Price and Availability of T865-3350, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T865-3350 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T865-3350
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T865-3350
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T865-3350 available by request